Safety and feasibility of laparoscopic liver resection for hepatocellular carcinoma with clinically significant portal hypertension: a propensity score-matched study
Authors:
- 6 July 2020
- journal article
- research article
- Published by Springer Nature in Surgical Endoscopy
- Vol. 35 (7) , 3267-3278
Abstract
Background The presence of clinically significant portal hypertension (CSPH) remains a relative contraindication to liver resection for patients with resectable hepatocellular carcinoma (HCC). The goal of this study was to explore whether a laparoscopic approach could extend the indications for hepatectomy to patients with PH. Method Patients who underwent laparoscopic liver resection (LLR) from February 2016 to September 2019 performed by a single medical team were included in this study. We analyzed the surgical and oncological outcomes between groups with and without CSPH before and after propensity score matching (PSM). Result We enrolled 156 patients divided into two groups according to the presence (CSPH, n = 26) or absence (non-CSPH, n = 130) of CSPH. CSPH group was associated with more clinical signs of liver dysfunction (p < 0.05). After PSM (n = 48 patients), the CSPH group tended to have a longer postoperative hospital stay (p = 0.054); however, there was no difference in operation time (p = 0.329), blood loss volume (p = 0.392), transfusion rates (p = 0.701), rate of conversion to open surgery (p = 0.666), surgical margin (p = 0.306), surgical mortality (n = 0), or comprehensive complication index (p = 0.844) between the two groups. The median follow-up time for the entire cohort was 19.6 months (range 0.2–40.6 months). The 3-year overall survival rate was 62.9% in the CSPH group and 84.3% in the non-CSPH group (p = 0.1090), and results were similar after PSM (p = 0.5734). Conclusions LLR is safe and feasible for HCC with PH. The introduction of minimally invasive surgery, represented by LLR, can appropriately expand the indications for hepatectomy.Keywords
Funding Information
- National Natural Science Foundation of China (81827804)
- Scientific research fund of National Health Commission of China- Major science and technology plan of Zhejiang province (WKJ-ZJ-2030)
This publication has 49 references indexed in Scilit:
- Influence of clinically significant portal hypertension on survival after hepatic resection for hepatocellular carcinoma in cirrhotic patientsLiver International, 2013
- An Introduction to Propensity Score Methods for Reducing the Effects of Confounding in Observational StudiesMultivariate Behavioral Research, 2011
- Management of Hepatocellular Carcinoma: An Update ΔσHepatology, 2011
- The International Position on Laparoscopic Liver SurgeryAnnals of Surgery, 2009
- Preoperative evaluation of hepatic functional reserve by converted ICGR15 calculated from 99mTc‐GSA scintigraphyJournal of Gastroenterology and Hepatology, 2008
- Short- and Long-Term Outcomes after Hepatic Resection for Hepatocellular Carcinoma with Concomitant Esophageal Varices in Patients with CirrhosisAnnals of Surgical Oncology, 2008
- Measurement of Portal Pressure and Its Role in the Management of Chronic Liver DiseaseSeminars in Liver Disease, 2006
- The ???50-50 Criteria??? on Postoperative Day 5Annals of Surgery, 2005
- Classification of Surgical ComplicationsAnnals of Surgery, 2004
- Surgical resection of hepatocellular carcinoma. Post-operative outcome and long-term results in Europe: An overviewLiver Transplantation, 2004